Building Space Planes with Sassie Duggleby of Venus Aerospace

Building Space Planes with Sassie Duggleby of Venus Aerospace
Near Frontier
Building Space Planes with Sassie Duggleby of Venus Aerospace
/
Episode 6 May 23, 2022 00:59:43

Hosted By

Ian Rountree Amee Kapadia Andrew Kirima

Show Notes

Today we're joined by Sassie Duggleby, co-founder and CEO of Venus Aerospace. Venus is a Houston-based aerospace company building hypersonic space planes that fly at Mach 9 taking you anywhere in the world within an hour. We talk about hypersonics, challenges in building airframes that can support hypersonic speeds, and how Sassie has built an inclusive and balanced culture at Venus. If you're curious about the future of transportation, then this episode is for you. 

Twitter: Venus Aerospace, Sassie Duggleby

Website: Venus Aerospace

Other Episodes

January 25, 2022

RNA Delivery with Anna Perdrix and George Foot of Sixfold Bioscience

Today we're joined by Anna Perdrix Rossell and George Foot of Sixfold Bioscience, co-founders of Sixfold Bioscience, a UK based biotech company using computation and advanced chemistry to engineer highly programmable constructs that make the delivery of RNA therapeutics predictable and precise. Sixfold's technology expands the purview of RNA therapeutics from vaccines to all diseases, starting with cancer. In our conversation, we discuss the challenge of RNA delivery, what it's like starting a biotech company totally from scratch (no academic spinout or venture incubation), how to hire a diverse team, and promising areas of biotechnology.    Shownotes: Get in touch with the Sixfold team: Sixfold Bioscience; George Foot; Anna Perdrix Interested in joining the team? Check out open roles here In this episode, we cover:  Sixfold Bioscience and challenges with RNA delivery  How George and Anna started Sixfold Switching between an academia and entrepreneurship mindset Building a biotech totally from scratch Twitter debate—founder led bio vs venture incubation  Building a diverse (majority women!) team and tips for recruitment Sixfold's big vision Broader trends to be excited about in biotech and deep tech ...

Play

00:43:57

February 09, 2022

The Deep Tech Decade: Cantos Chats Where Deep Tech is Headed in 2022

Cantos analysts Amee and Andrew dive into their top predictions for what deep tech might see in 2022.  Shownotes: Our 2022 predictions blog post Trailblazer's List by Mina Fahmi: https://trailblazerlist.xyz/ Loonshots by Safi Bahcall Speed & Scale by John Doerr New funding models in biotech Nuclear energy blog post ...

Play

00:29:53

February 22, 2022

Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech

Today we're joined by Dr. Joshua Britton, founder and CEO of Debut Biotech, a cell-free biomanufacturing company. Josh gives us a crash course on synthetic biology and biomanufacturing, walking us through the various methods and promise of this industry that may very well shift industrial production away from fossil fuels. We also get into some of the founding story of Debut, including how Cantos' investment in Debut came to be...hint: it had to do with a cold message.  Shownotes: Power: Limits and Prospects foor Human Survial by Richard Heinberg McKinsey report on synthetic biology Debut Biotech on Twitter ...

Play

00:56:28